Home
Categories
EXPLORE
Society & Culture
Comedy
True Crime
History
Science
Education
News
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/31/47/16/314716b2-e1db-31fb-ba95-aab46d5de258/mza_15406322430643846600.jpg/600x600bb.jpg
The Lancet Gastroenterology & Hepatology in conversation with
The Lancet Group
46 episodes
1 day ago
Do wheat or gluten trigger IBS symptoms? We spoke to Premysl Bercik about a randomised, double-blind, sham-controlled crossover trial that challenged adults with IBS—who reported benefit from a gluten-free diet—with wheat, gluten, or a gluten-free sham to test symptom and behavioural responses. Click here to read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00090-1/fulltext Continue this conversation on social! Follow us today at... https://bsky...
Show more...
Medicine
Education,
Health & Fitness,
Science,
Life Sciences
RSS
All content for The Lancet Gastroenterology & Hepatology in conversation with is the property of The Lancet Group and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Do wheat or gluten trigger IBS symptoms? We spoke to Premysl Bercik about a randomised, double-blind, sham-controlled crossover trial that challenged adults with IBS—who reported benefit from a gluten-free diet—with wheat, gluten, or a gluten-free sham to test symptom and behavioural responses. Click here to read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00090-1/fulltext Continue this conversation on social! Follow us today at... https://bsky...
Show more...
Medicine
Education,
Health & Fitness,
Science,
Life Sciences
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/31/47/16/314716b2-e1db-31fb-ba95-aab46d5de258/mza_15406322430643846600.jpg/600x600bb.jpg
Peter De Cruz on the PREDICT-UC trial of intensified versus standard dose infliximab for steroid-refractory acute severe ulcerative colitis
The Lancet Gastroenterology & Hepatology in conversation with
14 minutes
1 year ago
Peter De Cruz on the PREDICT-UC trial of intensified versus standard dose infliximab for steroid-refractory acute severe ulcerative colitis
Peter De Cruz (University of Melbourne) discusses the PREDICT-UC trial of intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis.Read the full article:https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00200-0?dgcid=buzzsprout_icw_podcast_generic_langasContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljourna...
The Lancet Gastroenterology & Hepatology in conversation with
Do wheat or gluten trigger IBS symptoms? We spoke to Premysl Bercik about a randomised, double-blind, sham-controlled crossover trial that challenged adults with IBS—who reported benefit from a gluten-free diet—with wheat, gluten, or a gluten-free sham to test symptom and behavioural responses. Click here to read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00090-1/fulltext Continue this conversation on social! Follow us today at... https://bsky...